Identification and targeting leukemia stem cells: The path to the cure for acute myeloid leukemia

Por Zhou, Jianbiao, Chng, Wee-Joo
Publicado em 2014

Aberrant RNA splicing and mutations in spliceosome complex in acute myeloid leukemia

Por Zhou, Jianbiao, Chng, Wee-Joo
Publicado no Stem Cell Investig (2017)

Aberrant nuclear factor-kappa B activity in acute myeloid Leukemia: from molecular pathogenesis to therapeutic target

Por Zhou, Jianbiao, Ching, Ying Qing, Chng, Wee-Joo
Publicado no Oncotarget (2015)

The emerging roles of exosomes in leukemogeneis

Por Zhou, Jianbiao, Wang, Sam, Sun, Kangyun, Chng, Wee-Joo
Publicado no Oncotarget (2016)

ABT-869, a promising multi-targeted tyrosine kinase inhibitor: from bench to bedside

Por Zhou, Jianbiao, Goh, Boon-Cher, Albert, Daniel H, Chen, Chien-Shing
Publicado em 2009

p53 mutations in colorectal cancer- molecular pathogenesis and pharmacological reactivation

Por Li, Xiao-Lan, Zhou, Jianbiao, Chen, Zhi-Rong, Chng, Wee-Joo
Publicado no World J Gastroenterol (2015)

PRIMA-1(met) (APR-246) inhibits growth of colorectal cancer cells with different p53 status through distinct mechanisms

Por Li, Xiao-Lan, Zhou, Jianbiao, Chan, Zit-Liang, Chooi, Jing-Yuan, Chen, Zhi-Rong, Chng, Wee-Joo
Publicado no Oncotarget (2015)

Genome-wide pharmacologic unmasking identifies tumor suppressive microRNAs in multiple myeloma

Por Bi, Chonglei, Chung, Tae-Hoon, Huang, Gaofeng, Zhou, Jianbiao, Yan, Junli, Ahmann, Gregory J., Fonseca, Rafael, Chng, Wee Joo
Publicado no Oncotarget (2015)

The Slow-Releasing Hydrogen Sulfide Donor, GYY4137, Exhibits Novel Anti-Cancer Effects In Vitro and In Vivo

Por Lee, Zheng Wei, Zhou, Jianbiao, Chen, Chien-Shing, Zhao, Yujun, Tan, Choon-Hong, Li, Ling, Moore, Philip Keith, Deng, Lih-Wen
Publicado em 2011

Determinants of Sensitivity to DZNep Induced Apoptosis in Multiple Myeloma Cells

Por Xie, Zhigang, Bi, Chonglei, Cheong, Lip Lee, Liu, Shaw Cheng, Huang, Gaofeng, Zhou, Jianbiao, Yu, Qiang, Chen, Chien-Shing, Chng, Wee Joo
Publicado em 2011

The pro-metastasis tyrosine phosphatase, PRL-3 (PTP4A3), is a novel mediator of oncogenic function of BCR-ABL in human chronic myeloid leukemia

Por Zhou, Jianbiao, Cheong, Lip-Lee, Liu, Shaw-Cheng, Chong, Phyllis SY, Mahara, Sylvia, Bi, Chonglei, Ong, Kelly OK, Zeng, Qi, Chng, Wee Joo
Publicado em 2012

Quantitative analysis of minimal residual disease predicts relapse in children with B-lineage acute lymphoblastic leukemia in DFCI ALL Consortium Protocol 95-01

Por Zhou, Jianbiao, Goldwasser, Meredith A, Li, Aihong, Dahlberg, Suzanne E., Neuberg, Donna, Wang, Hongjun, Dalton, Virginia, McBride, Kathryn D, Sallan, Stephen E., Silverman, Lewis B, Gribben, John G.
Publicado em 2007

Engineering the First Chimeric Antibody in Targeting Intracellular PRL-3 Oncoprotein for Cancer Therapy in Mice

Por Guo, Ke, Tang, Jing Ping, Jie, Li, Al-Aidaroos, Abdul Qader O., Hong, Cheng William, Tan, Cheng Peow Bobby, Park, Jung Eun, Varghese, Leyon, Feng, Zhiwei, Zhou, Jianbiao, Chng, Wee Joo, Zeng, Qi
Publicado em 2012

Functional Characterization of D9, a Novel Deazaneplanocin A (DZNep) Analog, in Targeting Acute Myeloid Leukemia (AML)

Por Jiang, Xia, Lim, Cheryl Zi Hui, Li, Zhimei, Lee, Puay Leng, Yatim, Siti Maryam J. M., Guan, Peiyong, Li, Juntao, Zhou, Jianbiao, Pan, Jingxuan, Chng, Wee-Joo, Chai, Christina L. L., Yu, Qiang
Publicado no PLoS One (2015)

PRL-3, a Metastasis Associated Tyrosine Phosphatase, Is Involved in FLT3-ITD Signaling and Implicated in Anti-AML Therapy

Por Zhou, Jianbiao, Bi, Chonglei, Chng, Wee-Joo, Cheong, Lip-Lee, Liu, Shaw-Cheng, Mahara, Sylvia, Tay, Kian-Ghee, Zeng, Qi, Li, Jie, Guo, Ke, Tan, Cheng Peow Bobby, Yu, Hanry, Albert, Daniel H., Chen, Chien-Shing
Publicado em 2011

ITIH3 Is a Potential Biomarker for Early Detection of Gastric Cancer

Por Chong, Poh Kuan, Lee, Huiyin, Zhou, Jianbiao, Liu, Shaw-Cheng, Shia Loh, Marie Chiew, Wang, Ting Ting, Chan, Siew Pang, Smoot, Duane T., Ashktorab, Hassan, Yan So, Jimmy Bok, Lim, Khong Hee, Yeoh, Khay Guan, Lim, Yoon Pin
Publicado em 2010